Study on interaction of ginsenosides with bovine or human serum albumin using wavelength modulation surface plasmon resonance biosensor

被引:4
作者
Liu, X [1 ]
Sun, Y
Song, DQ
Li, XW
Zhang, QL
Tian, Y
Liu, ZY
Zhang, HQ
机构
[1] Jilin Univ, Coll Chem, Changchun 130012, Jilin, Peoples R China
[2] Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China
关键词
ginsenoside-serum albumin interaction; surface plasmon resonance; wavelength modulation; bound percentage;
D O I
10.1002/cjoc.200690126
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
To use a newly developed wavelength modulation surface plasmon resonance (SPR) biosensor, an experimental protocol was developed to investigate the interaction of ginsenosides with serum albumin. With a known concentration of the ginsenosides, bound percentages of the ginsenosides with human serum albumin (HSA) or bovine serum albumin (BSA) were obtained. SPR technique could require no labeling and this method provided the detailed information on association and disassociation of molecules in real time. The results indicate that the sensitivity of wavelength modulation SPR biosensor is sufficient for detection and characterization of binding events involving low-molecular weight compounds and their immobilized protein targets.
引用
收藏
页码:660 / 664
页数:5
相关论文
共 27 条
[1]   Use of surface plasmon resonance biosensor technology as a possible alternative to detect differences in binding of enantiomeric drug compounds to immobilized albumins [J].
Ahmad, A ;
Ramakrishnan, A ;
McLean, MA ;
Breau, AP .
BIOSENSORS & BIOELECTRONICS, 2003, 18 (04) :399-404
[2]  
AHMAD A, 2002, BIOSENS BIOELECTRON, V17, P1
[3]  
ANNA S, 2002, J MOL STRUCT, V614, P227
[4]   Biosensor profiling of molecular interactions in pharmacology [J].
Cooper, MA .
CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (05) :557-562
[5]   Characterizing a drug's primary binding site on albumin [J].
Day, YSN ;
Myszka, DG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (02) :333-343
[6]  
Ding YS, 2001, ELECTROPHORESIS, V22, P2210, DOI 10.1002/1522-2683(20017)22:11<2210::AID-ELPS2210>3.0.CO
[7]  
2-W
[8]   Species-dependency in chiral-drug recognition of serum albumin studied by chromatographic methods [J].
Fitos, I ;
Visy, J ;
Simonyi, M .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 2002, 54 (1-3) :71-84
[9]   An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma [J].
Fogli, S ;
Danesi, R ;
Innocenti, F ;
Di Paolo, A ;
Bocci, G ;
Barbara, C ;
Del Tacca, M .
THERAPEUTIC DRUG MONITORING, 1999, 21 (03) :367-375
[10]   Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels [J].
Frostell-Karlsson, Å ;
Remaeus, A ;
Roos, H ;
Andersson, K ;
Borg, P ;
Hämäläinen, M ;
Karlsson, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (10) :1986-1992